日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

(191)Pt-labeled trithiol-Hoechst-PSMA: preliminary evaluation of conjugates designed for delivery to genomic DNA of PSMA-positive cancers

(191)Pt标记的三硫醇-Hoechst-PSMA:用于递送至PSMA阳性癌症基因组DNA的缀合物的初步评估

Obata, Honoka; Tsuji, Atsushi B; Feng, Yutian; Zheng, Yongxiang; Sugyo, Aya; Sudo, Hitomi; Kajiwara, Chie; Minegishi, Katsuyuki; Zhang, Ming-Rong; Zalutsky, Michael R

Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell-Engaging Antibody in GBM via Passive and Active Mechanisms.

纵向成像揭示了双特异性 T 细胞结合抗体在胶质母细胞瘤中通过被动和主动机制被肿瘤吸收和长期保留

Feng Yutian, Haupt Benedikt, Huynh Truc T, Meshaw Rebecca, Martin-Regalado Angela, Thakur Aditi, Duffy Joseph T, Alzeer Abdulaziz, Siegel David A, Barnes Ashlynn, Simberg Dmitri, Zalutsky Michael R, Balyasnikova Irina V

Enhancing the therapeutic index of [(211)At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glands

利用碘化物假载体提高[(211)At]YF2的治疗指数:一种减少其在肾脏、唾液腺和泪腺中蓄积的简便策略

Huynh, Truc T; Feng, Yutian; Banks, Rebecca L; Vaidyanathan, Ganesan; Zalutsky, Michael R

Nucleic acid therapeutics for liver diseases: A decade of technological convergence and clinical challenges

核酸疗法在肝病治疗中的应用:十年技术融合与临床挑战

Pan, Yufei; Pan, Mingyue; Huang, Yuanzheng; Lian, Baoping; Feng, Yutian; Liu, Juan; Liu, Xiaoxuan

Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations

组织工程用生物活性支架:脱细胞细胞外基质的应用与创新综述

Liu, Juan; Song, Qingru; Yin, Wenzhen; Li, Chen; An, Ni; Le, Yinpeng; Wang, Qi; Feng, Yutian; Hu, Yuelei; Wang, Yunfang

A third generation PSMA-targeted agent [(211)At]YF2: Synthesis and in vivo evaluation

第三代PSMA靶向药物[(211)At]YF2:合成及体内评价

Feng, Yutian; Meshaw, Rebecca L; Finch, Sean W; Zheng, Yongxiang; Minn, Il; Vaidyanathan, Ganesan; Pomper, Martin G; Zalutsky, Michael R

Innovations in 3D bioprinting and biomaterials for liver tissue engineering: Paving the way for tissue-engineered liver

3D生物打印和生物材料在肝组织工程中的创新:为组织工程肝脏铺平道路

Wang, Qi; Feng, Yutian; Wang, Anqi; Hu, Yuelei; Cao, Yannan; Zheng, Jingjing; Le, Yinpeng; Liu, Juan

Improving Phylogenies Based on Average Nucleotide Identity, Incorporating Saturation Correction and Nonparametric Bootstrap Support

基于平均核苷酸同一性改进系统发育树,纳入饱和度校正和非参数自举支持

Gosselin, Sean; Fullmer, Matthew S; Feng, Yutian; Gogarten, Johann Peter

An Improved (211)At-Labeled Agent for PSMA-Targeted α-Therapy

一种改进的(211)At标记的PSMA靶向α疗法药物

Mease, Ronnie C; Kang, Choong Mo; Kumar, Vivek; Banerjee, Sangeeta Ray; Minn, Il; Brummet, Mary; Gabrielson, Kathleen L; Feng, Yutian; Park, Andrew; Kiess, Ana P; Sgouros, George; Vaidyanathan, Ganesan; Zalutsky, Michael R; Pomper, Martin G

Gold Nanostars: A Novel Platform for Developing (211)At-Labeled Agents for Targeted Alpha-Particle Therapy

金纳米星:一种用于开发靶向α粒子治疗的(211)At标记剂的新型平台

Liu, Yang; Zhou, Zhengyuan; Feng, Yutian; Zhao, Xiao-Guang; Vaidyanathan, Ganesan; Zalutsky, Michael R; Vo-Dinh, Tuan